Navigation Links
20 Swiss Biotech Firms and Organizations will Populate the Swiss Pavilion at BIO 2013 International Convention
Date:4/16/2013

NEW YORK, April 16, 2013 /PRNewswire/ -- Twenty Swiss-based biotech industry companies and organizations are highlighting their expertise at the Swiss Pavilion (Booth 5454, Hall A) during the BIO International Convention April 22-25 in Chicago, reports Daniel Bangser, Director North America for Switzerland Trade & Investment Promotion. Some 150 additional representatives of biotech firms in Switzerland are expected to attend.

Presentations include:

Advances and Emerging Trends in the Swiss Biotech Market, with Nic Alexakis , CEO of the Swiss Biotech Association, and Juergen Regenold , CEO of regulanet (Monday Apr 22, 10:00 AM - 10:45 AM)

Summary of the Swiss Biotech Report 2013

For 2012, net sales in the Swiss biotech industry remained stable despite the European debt crisis. Biotech activities of Swiss companies remained high as revealed by the number of products in the clinical pipeline.

  • Net sales amounted to a total of CHF 4,642 billion, about 1% less than the previous year.
  • Capital investments in Swiss biotech companies amounted to approximately CHF 260 million. Though significantly lower than 2011, the overall picture looks similar when debt financing is removed from the analysis.
  • The number of biotech firms increased slightly from the previous year to 250 developers and suppliers. The number of employees totals over 13,700.

"A well-functioning transfer of knowledge and technology combined with a high degree of innovation are key components of Switzerland's prosperity," Mr. Bangser said.  "Swiss biotech companies play an important role in this process.  Success is largely due to the excellent cooperation between universities, research netwo
'/>"/>

SOURCE Switzerland Trade & Investment Promotion
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. VBI’s Dr. Szczepan Baran is an Invited Speaker at the Swiss Laboratory Animal (SGV) National Meeting
2. JBT Corporation and Swisslog Enter Into Partnership for Automated Guided Vehicles
3. Swiss, EMA, US Pharmacopoeia and World Health Organization Authorities to Provide an Update on Cool Chain Regulations
4. Fytofontana Cosmeceuticals: The Swiss Secret For Incredibly Young And Beautiful Skin
5. Heptares to Present at Upcoming Scientific and Biotech Industry Conferences
6. Global Biotechnology Industry Market Research Report Now Available from IBISWorld
7. PharmaDirections Celebrates 10 Years of Success for Their Virtual Biotech and Pharmaceutical Clients
8. Life Technologies Acquires KDR Biotech Co., LTD., Leading Reagents Distributor
9. Gene Therapy Developed for ALS Treatment: New Biotech Company Neuralgene Enters Evaluation Phase
10. Plandai Biotechnology, Inc. Updates Progress Of Preparing Products For Market
11. San Diego State University Hosts Open House for Life Science Immersion Biotechnology Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Pittsburgh, PA (PRWEB) February 26, 2015 ... March 9 -12, at the Ernest N. Morial ... 919 exhibitors (count as of February 19, 2015) ... community in industrial, academic, and government labs. The ... such as, but not limited to, analytical chemistry; ...
(Date:2/26/2015)... Innovation is more urgent than ... parts of the world and transforming global markets ... manufacturing to health care, disruption is constantly underway. ... socio-political trends shake the foundations of established business ... CEOs to survive the next wave of mega-change. ...
(Date:2/26/2015)... According to a new market report published by ... (Corn, Soybean, Cotton and Others), Synthetic Biology-Enabled Products and ... and Forecast, 2013 – 2019,”the global agricultural biotechnology market ... is expected to reach USD 28,694.1 million by 2019, ... 2019. , Demand for food production has increased ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 Regis Technologies ... the development of oncology drug substances. , Regis Technologies ... of their new Potent Compound Suite (PCS) for 2015. ... 36,000 square foot, cGMP facility in Morton Grove, Illinois. ... manufacturing of potent compounds up to about one kilogram ...
Breaking Biology Technology:Pittcon 2015 Announces Exposition Highlights 2One Million Acts of Innovation Canada Creates Partnership with The Economist Events’ Innovation Forum 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 3Regis Extends cGMP Services to Oncology Market 2
... , , , ... AMGN ) today announced detailed results from a Phase ... the treatment of bone metastases in 2,046 patients with advanced ... demonstrated superior efficacy compared to Zometa. These results were presented ...
... ... answer the question, "Is the Jatropha sector becoming a DotCom Bubble?". 2nd JatrophaWorld ... Viridesco Ltd. will discuss the challenges, controversies & paradoxes of the nascent Jatropha non-food ... ...
... has become just another fixture, it,s time to take a ... used to develop paper-based biosensors that can detect certain harmful ... bioterrorism agents. In a paper published in the July ... research team at McMaster University, working with the Sentinel Bioactive ...
Cached Biology Technology:Denosumab Demonstrates Superiority Over Zometa(R) in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients 2Denosumab Demonstrates Superiority Over Zometa(R) in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients 3Denosumab Demonstrates Superiority Over Zometa(R) in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients 4Denosumab Demonstrates Superiority Over Zometa(R) in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients 5Denosumab Demonstrates Superiority Over Zometa(R) in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients 6Denosumab Demonstrates Superiority Over Zometa(R) in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients 7Denosumab Demonstrates Superiority Over Zometa(R) in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients 8Denosumab Demonstrates Superiority Over Zometa(R) in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients 9Will Jatropha Become a 'DotCom Bubble' in Biofuel Industry? Leading to 2nd JatrophaWorld Africa, Jatropha Webinar on 30 Sept 09 Explores Challenges & Offers Strategies for Long-Term Success for This Non-Food Crop for Fuel 2Toxin detection as close as an inkjet printer 2
(Date:1/22/2015)... , Jan. 9, 2015 Valid S.A. ("Company") (BM&FBOVESPA: ... market in general the State of Washington,s ... for a new enrollment and central issuance system for driver,s ... The project planning and development will start in ...
(Date:1/22/2015)... Wis. , Jan. 15, 2015  BellBrook Labs, ... drug discovery, announced the launch of a TR-FRET ... the company,s Transcreener UDP Assay, a high throughput ... The new assay will allow for sensitive detection ...
(Date:1/22/2015)... YORK , Jan. 21, 2015  Analyst Report Issued by ... Card Brands report showed that planet-wide, transactions at merchants on ... while the total number of credit, debit, and prepaid cards ... U.S. were victims of fraudulent card usage in 2012, and ...
Breaking Biology News(10 mins):Valid USA Signs Contract For Washington Driver's License Issuance 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2
... April 2012 -- New techniques for identifying lung cancer ... nanotech ,nose, and a method to examine the cells ... presentations at the 3rd European Lung Cancer Conference (ELCC) ... is vital to improve lung cancer survival rates," commented ...
... new studies that may help doctors tailor lung cancer ... their tumors are being presented at the 3rd European ... of lung cancer treatment is to tailor the treatment ... Christie NHS Foundation Trust in Manchester, UK. "The studies ...
... Patients with advanced non-small cell lung cancer should only ... chemotherapy if their tumor is known to harbor EGFR ... Conference in Geneva, Switzerland. The results of ... that patients with unknown or negative mutation status should ...
Cached Biology News:Early detection techniques offer hope for improved outcomes in lung cancer patients 2Early detection techniques offer hope for improved outcomes in lung cancer patients 3Early detection techniques offer hope for improved outcomes in lung cancer patients 4Advances in personalized medicine for lung cancer 2Advances in personalized medicine for lung cancer 3Advances in personalized medicine for lung cancer 4Advances in personalized medicine for lung cancer 5New analysis helps guide use of erlotinib in advanced non-small cell lung cancer 2New analysis helps guide use of erlotinib in advanced non-small cell lung cancer 3
...
... Edited by R. Edwards ... on all types of immunoassays, ... surface immunoassays and on the ... immunoassays. Essential information is also ...
ANTI S. ENTERID LPS...
B.D. Hames and D.M. Glover (1996) • This issue covers T-Cell antigen receptor genes; T-Lymphocyte signal transduction; B-Cell activation antibody engineering and the complement system and other ...
Biology Products: